ETHFI / USDC

ETHFI / FDUSD

ETHFI / USDT

ETHFI / TRY

CVC / USDC

ZIL / BTC

MASK / TRY

MASK / USDT

TRX / XRP

XVG / ETH

PEOPLE / TRY

PEOPLE / USDC

PEOPLE / USDT

PEOPLE / FDUSD

PEOPLE / BTC

GPS / FDUSD

GUN / USDT

GUN / TRY

GUN / BNB

GUN / USDC

BANNARI AMMAN SPINNING

RUDRABHISHEK ENTERP LTD

MOTOR & GENERAL FINANCE L

INNOMET ADVANCED MATERI L

NELCAST LIMITED

HCL INFOSYSTEMS LTD

INTENSE TECHNOLOGIES LTD

KIRLOSKAR OIL ENG LTD

TANKUP ENGINEERS LIMITED

BLS E-SERVICES LIMITED

WENDT (INDIA) LIMITED

AVANTEL LIMITED

SOLARA ACTIVE PHA SCI LTD

MAX INDIA LTD

MICROPRO SOFTWARE SOL L

DAM CAPITAL ADVISORS LTD

SYNERGY GREEN IND. LTD

MUTHOOT CAP SERV LTD

COASTAL CORPORATION LTD

HIKAL LIMITED

Click here to get full coverage on Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure - Moneycontrol

Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure  Moneycontrol

Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure - Moneycontrol

Click here to get full coverage on Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Well Worth Watching - simplywall.st

Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Well Worth Watching  simplywall.st

Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Well Worth Watching - simplywall.st

Click here to get full coverage on Nifty Pharma Index cracks 2% as Trump proposes drug price cuts; Sun Pharma dips 5% - Mint

Nifty Pharma Index cracks 2% as Trump proposes drug price cuts; Sun Pharma dips 5%  Mint

Nifty Pharma Index cracks 2% as Trump proposes drug price cuts; Sun Pharma dips 5% - Mint

Click here to get full coverage on Sun Pharma to Acquire Checkpoint Therapeutics - PR Newswire

Sun Pharma to Acquire Checkpoint Therapeutics  PR Newswire

Sun Pharma to Acquire Checkpoint Therapeutics - PR Newswire

Click here to get full coverage on Why Sun Pharma Could Face Pricing Pressure Due To Trumps Drug Cost Reductions - NDTV Profit

Why Sun Pharma Could Face Pricing Pressure Due To Trumps Drug Cost Reductions  NDTV Profit

Why Sun Pharma Could Face Pricing Pressure Due To Trumps Drug Cost Reductions - NDTV Profit

Click here to get full coverage on Sun Pharma snags appeals win over Incyte, clearing way for US launch of alopecia med Leqselvi - Fierce Pharma

Sun Pharma snags appeals win over Incyte, clearing way for US launch of alopecia med Leqselvi  Fierce Pharma

Sun Pharma snags appeals win over Incyte, clearing way for US launch of alopecia med Leqselvi - Fierce Pharma

Click here to get full coverage on India's Sun Pharma aims to launch its obesity drug in five years, managing director says - Reuters

India's Sun Pharma aims to launch its obesity drug in five years, managing director says  Reuters

India's Sun Pharma aims to launch its obesity drug in five years, managing director says - Reuters

Click here to get full coverage on Sun Pharma To Open New Headquarters In Princeton Area: NJEDA - Patch

Sun Pharma To Open New Headquarters In Princeton Area: NJEDA  Patch

Sun Pharma To Open New Headquarters In Princeton Area: NJEDA - Patch

Click here to get full coverage on Sun Pharma agrees to acquire Checkpoint Therapeutics - Pharmaceutical Technology

Sun Pharma agrees to acquire Checkpoint Therapeutics  Pharmaceutical Technology

Sun Pharma agrees to acquire Checkpoint Therapeutics - Pharmaceutical Technology

Click here to get full coverage on Sun Pharma shares fall up to 7% after Trump plans to cut prescription drug prices by up to 80% - CNBC TV18

Sun Pharma shares fall up to 7% after Trump plans to cut prescription drug prices by up to 80%  CNBC TV18

Sun Pharma shares fall up to 7% after Trump plans to cut prescription drug prices by up to 80% - CNBC TV18

Click here to get full coverage on Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure - TradingView

Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure  TradingView

Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure - TradingView

Click here to get full coverage on Sun Pharma expanding Princeton HQ with $5.2M in tax credits - NJBIZ

Sun Pharma expanding Princeton HQ with $5.2M in tax credits  NJBIZ

Sun Pharma expanding Princeton HQ with $5.2M in tax credits - NJBIZ

Click here to get full coverage on Pharma Index Bounces Back After Trump's Drug Order Causes 500 Point Fall | Sun Pharma, Biocon Prices - MSN

Pharma Index Bounces Back After Trump's Drug Order Causes 500 Point Fall | Sun Pharma, Biocon Prices  MSN

Pharma Index Bounces Back After Trump's Drug Order Causes 500 Point Fall | Sun Pharma, Biocon Prices - MSN

Click here to get full coverage on Trump drug price order: Nomura says Sun Pharma may be hit hardest, uncertainty looms ahead - The Financial Express

Trump drug price order: Nomura says Sun Pharma may be hit hardest, uncertainty looms ahead  The Financial Express

Trump drug price order: Nomura says Sun Pharma may be hit hardest, uncertainty looms ahead - The Financial Express

Click here to get full coverage on Sun Pharma to buy cash-strapped Checkpoint for $355M upfront - FirstWord

Sun Pharma to buy cash-strapped Checkpoint for $355M upfront  FirstWord

Sun Pharma to buy cash-strapped Checkpoint for $355M upfront - FirstWord

Click here to get full coverage on Sun Pharma secures EDA tax credit for new 100,000 sq. ft. headquarters near Princeton - RE-NJ

Sun Pharma secures EDA tax credit for new 100,000 sq. ft. headquarters near Princeton  RE-NJ

Sun Pharma secures EDA tax credit for new 100,000 sq. ft. headquarters near Princeton - RE-NJ

Click here to get full coverage on Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 12 May 2025 - Mint

Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 12 May 2025  Mint

Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 12 May 2025 - Mint

Click here to get full coverage on India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million - Reuters

India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million  Reuters

India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million - Reuters

Click here to get full coverage on On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M - Fierce Pharma

On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M  Fierce Pharma

On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M - Fierce Pharma

Click here to get full coverage on Top Indian drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales - Reuters

Top Indian drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales  Reuters

Top Indian drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales - Reuters

Click here to get full coverage on Sun Pharmaceutical Industries (NSE:SUNPHARMA) stock performs better than its underlying earnings growth over last five years - simplywall.st

Sun Pharmaceutical Industries (NSE:SUNPHARMA) stock performs better than its underlying earnings growth over last five years  simplywall.st

Sun Pharmaceutical Industries (NSE:SUNPHARMA) stock performs better than its underlying earnings growth over last five years - simplywall.st

Click here to get full coverage on Sun Pharma can launch alopecia drug Leqselvi in US as court removes injunction | Company Business News - Mint

Sun Pharma can launch alopecia drug Leqselvi in US as court removes injunction | Company Business News  Mint

Sun Pharma can launch alopecia drug Leqselvi in US as court removes injunction | Company Business News - Mint

Click here to get full coverage on NSE/BSE, Top Gainers & Top Losers Today 13 May 2025: Sun Pharma, Adani Ports, TCS, Infosys among movers - BusinessLine

NSE/BSE, Top Gainers & Top Losers Today 13 May 2025: Sun Pharma, Adani Ports, TCS, Infosys among movers  BusinessLine

NSE/BSE, Top Gainers & Top Losers Today 13 May 2025: Sun Pharma, Adani Ports, TCS, Infosys among movers - BusinessLine

Click here to get full coverage on Sun Pharma Accuses Drugstores Of $10M Refund Scheme - Law360

Sun Pharma Accuses Drugstores Of $10M Refund Scheme  Law360

Sun Pharma Accuses Drugstores Of $10M Refund Scheme - Law360

Click here to get full coverage on Sun Pharma buys Checkpoint and its new cancer drug - pharmaphorum

Sun Pharma buys Checkpoint and its new cancer drug  pharmaphorum

Sun Pharma buys Checkpoint and its new cancer drug - pharmaphorum

Click here to get full coverage on Dr. Reddy’s, Sun Pharma and Zydus issue US recalls, citing failed specs and labeling issues - Fierce Pharma

Dr. Reddy’s, Sun Pharma and Zydus issue US recalls, citing failed specs and labeling issues  Fierce Pharma

Dr. Reddy’s, Sun Pharma and Zydus issue US recalls, citing failed specs and labeling issues - Fierce Pharma

Click here to get full coverage on Emerge Program Secures Sun Pharma’s Presence in NJ - New Jersey Business Magazine

Emerge Program Secures Sun Pharma’s Presence in NJ  New Jersey Business Magazine

Emerge Program Secures Sun Pharma’s Presence in NJ - New Jersey Business Magazine

Click here to get full coverage on Sun Pharma to Open New Plainsboro Headquarters - Community News

Sun Pharma to Open New Plainsboro Headquarters  Community News

Sun Pharma to Open New Plainsboro Headquarters - Community News

Click here to get full coverage on Sun Pharma, Zydus recall products in US: USFDA report - The Economic Times

Sun Pharma, Zydus recall products in US: USFDA report  The Economic Times

Sun Pharma, Zydus recall products in US: USFDA report - The Economic Times

Click here to get full coverage on India's Sun Pharma beats Q2 profit view on higher demand for specialty drugs - Reuters

India's Sun Pharma beats Q2 profit view on higher demand for specialty drugs  Reuters

India's Sun Pharma beats Q2 profit view on higher demand for specialty drugs - Reuters

Click here to get full coverage on Sun Pharma Presents LEQSELVI™ (deuruxolitinib) Data Highlighting Clinical Efficacy & Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference - PR Newswire

Sun Pharma Presents LEQSELVI™ (deuruxolitinib) Data Highlighting Clinical Efficacy & Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference  PR Newswire

Sun Pharma Presents LEQSELVI™ (deuruxolitinib) Data Highlighting Clinical Efficacy & Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference - PR Newswire

Click here to get full coverage on Sun Pharma tanks 7%, NIFTY PHARMA index down 2% as Trump makes this BIG announcement; all you need to know - Upstox

Sun Pharma tanks 7%, NIFTY PHARMA index down 2% as Trump makes this BIG announcement; all you need to know  Upstox

Sun Pharma tanks 7%, NIFTY PHARMA index down 2% as Trump makes this BIG announcement; all you need to know - Upstox

Click here to get full coverage on Sun Pharma to Declare Q4 Results on May 22, 2025 - Construction World

Sun Pharma to Declare Q4 Results on May 22, 2025  Construction World

Sun Pharma to Declare Q4 Results on May 22, 2025 - Construction World

Click here to get full coverage on Sun Pharma gets favourable order that paves way for Leqselvi's launch in America - Moneycontrol

Sun Pharma gets favourable order that paves way for Leqselvi's launch in America  Moneycontrol

Sun Pharma gets favourable order that paves way for Leqselvi's launch in America - Moneycontrol

Click here to get full coverage on Sun Pharma unit poised to buy Canadian biotech Antibe - pharmaphorum

Sun Pharma unit poised to buy Canadian biotech Antibe  pharmaphorum

Sun Pharma unit poised to buy Canadian biotech Antibe - pharmaphorum

Click here to get full coverage on Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn - Business Standard

Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn  Business Standard

Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn - Business Standard

Click here to get full coverage on Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher - Mint

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher  Mint

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher - Mint

Click here to get full coverage on Incyte wins injunction to block launch of Sun Pharma's JAK inhibitor Leqselvi - Fierce Pharma

Incyte wins injunction to block launch of Sun Pharma's JAK inhibitor Leqselvi  Fierce Pharma

Incyte wins injunction to block launch of Sun Pharma's JAK inhibitor Leqselvi - Fierce Pharma

Click here to get full coverage on Glenmark, Sun Pharma, Zydus Recall Products in US - Rediff MoneyWiz

Glenmark, Sun Pharma, Zydus Recall Products in US  Rediff MoneyWiz

Glenmark, Sun Pharma, Zydus Recall Products in US - Rediff MoneyWiz

Click here to get full coverage on Pharmazz Inc. and Sun Pharma entered into an agreement - GlobeNewswire

Pharmazz Inc. and Sun Pharma entered into an agreement  GlobeNewswire

Pharmazz Inc. and Sun Pharma entered into an agreement - GlobeNewswire

Click here to get full coverage on Sun Pharma vs Dr Reddy’s vs Lupin shares: Which pharma stock to buy after Trump tariffs? - Mint

Sun Pharma vs Dr Reddy’s vs Lupin shares: Which pharma stock to buy after Trump tariffs?  Mint

Sun Pharma vs Dr Reddy’s vs Lupin shares: Which pharma stock to buy after Trump tariffs? - Mint

Click here to get full coverage on Sun Pharma to acquire Checkpoint Therapeutics for $355 million in cash and milestone payments - CNBC TV18

Sun Pharma to acquire Checkpoint Therapeutics for $355 million in cash and milestone payments  CNBC TV18

Sun Pharma to acquire Checkpoint Therapeutics for $355 million in cash and milestone payments - CNBC TV18

Click here to get full coverage on Sun Pharma stock up 2.15% as US court clears alopecia drug launch - Business Standard

Sun Pharma stock up 2.15% as US court clears alopecia drug launch  Business Standard

Sun Pharma stock up 2.15% as US court clears alopecia drug launch - Business Standard

Click here to get full coverage on Sun Pharma introduces a novel class of drug Fexuclue in India - The Pharma Letter

Sun Pharma introduces a novel class of drug Fexuclue in India  The Pharma Letter

Sun Pharma introduces a novel class of drug Fexuclue in India - The Pharma Letter

Click here to get full coverage on Sun Pharma to acquire US oncology firm for over Rs 3000 crore - Times of India

Sun Pharma to acquire US oncology firm for over Rs 3000 crore  Times of India

Sun Pharma to acquire US oncology firm for over Rs 3000 crore - Times of India

Click here to get full coverage on Sun Pharma To Sell Some Merck Diabetes Drugs In India - CHEManager

Sun Pharma To Sell Some Merck Diabetes Drugs In India  CHEManager

Sun Pharma To Sell Some Merck Diabetes Drugs In India - CHEManager

Click here to get full coverage on Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million - Business Standard

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million  Business Standard

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million - Business Standard

Click here to get full coverage on Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News - Mint

Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News  Mint

Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News - Mint

Click here to get full coverage on Sun Pharma Announces Multiple Data Presentations Highlighting its Dermatology Portfolio to be Featured at the 2024 Fall Clinical Dermatology Conference - PR Newswire

Sun Pharma Announces Multiple Data Presentations Highlighting its Dermatology Portfolio to be Featured at the 2024 Fall Clinical Dermatology Conference  PR Newswire

Sun Pharma Announces Multiple Data Presentations Highlighting its Dermatology Portfolio to be Featured at the 2024 Fall Clinical Dermatology Conference - PR Newswire

Click here to get full coverage on Sun Pharma shares rally 5% after US court lifts launch restrictions on autoimmune drug - The Economic Times

Sun Pharma shares rally 5% after US court lifts launch restrictions on autoimmune drug  The Economic Times

Sun Pharma shares rally 5% after US court lifts launch restrictions on autoimmune drug - The Economic Times

Click here to get full coverage on US court lifts launch restrictions on Sun Pharma's autoimmune drug - Indian Pharma Post

US court lifts launch restrictions on Sun Pharma's autoimmune drug  Indian Pharma Post

US court lifts launch restrictions on Sun Pharma's autoimmune drug - Indian Pharma Post

Click here to get full coverage on Sun Pharmaceutical Industries Share Price - Business Standard

Sun Pharmaceutical Industries Share Price  Business Standard

Sun Pharmaceutical Industries Share Price - Business Standard

Click here to get full coverage on Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings - Business Standard

Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings  Business Standard

Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings - Business Standard

Click here to get full coverage on Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) most popular amongst private companies who own 43% of the shares, institutions hold 28% - simplywall.st

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) most popular amongst private companies who own 43% of the shares, institutions hold 28%  simplywall.st

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) most popular amongst private companies who own 43% of the shares, institutions hold 28% - simplywall.st

Sun Pharmaceutical Industries Limited (SUNPHARMA)

Price Chart

Key Statistics

Technicals

About SUNPHARMA

Latest News

Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure - Moneycontrol

Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Well Worth Watching - simplywall.st

Nifty Pharma Index cracks 2% as Trump proposes drug price cuts; Sun Pharma dips 5% - Mint

Environment, Social and Governance (ESG) Risk Ratings

Controversy Level

Advanced Charts

Top Gainers

Top Losers